Stock 2096 SIMCERE PHARMACEUTICAL GROUP LIMITED
Add to a list
To use this feature you must be a member
Log inSign up

Consensus Simcere Pharmaceutical Group Limited

Equities

2096

HK0000658531

Delayed Hong Kong S.E.
Other stock markets
 01:15:27 30/04/2024 pm IST 		5-day change 1st Jan Change
5.39 HKD -0.19% Intraday chart for Simcere Pharmaceutical Group Limited +3.26% -19.91%
25/04 Simcere Pharmaceutical’ Profit Down 23% in 2023 MT
10/04 Simcere Pharmaceutical's Cancer Drug Gets Fast Track Designation From US FDA MT

Evolution of the average Target Price on Simcere Pharmaceutical Group Limited

Price target over the last 5 years

History of analyst recommendation changes

ac86ab2e23d42e44.D9lHOHX4_AUNoDYypxn-4vwNvMsqHmsRg04K7PlrtKU.a68fTxqrrUFCxQNn5UiTz8o_5vJlfz1O7z1GppxGh5RinSViKs3IdU6TYw~df214d46e46321829af4602b7b2f5942

Analyst Recommendations on Simcere Pharmaceutical Group Limited

UBS Adjusts Simcere Pharmaceutical’s Price Target to HK$13 From HK$12.50, Keeps at Buy MT
UBS Adjusts Simcere Pharmaceutical’s Price Target to HK$12.50 From HK$11.80, Keeps at Buy MT
SIMCERE PHARMACEUTICAL : Nomura Starts Simcere Pharmaceutical Group at Buy With HK$10.1 Price Target MT
More recommendations

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
7
Last Close Price
4.995 CNY
Average target price
7.984 CNY
Spread / Average Target
+59.84%
High Price Target
9.246 CNY
Spread / Highest target
+85.11%
Low Price Target
7.088 CNY
Spread / Lowest Target
+41.90%

Consensus detail

Consensus revision (last 18 months)

Analysts covering Simcere Pharmaceutical Group Limited

UBS
Nomura

Ratings for Simcere Pharmaceutical Group Limited

Trading Rating
Investor Rating
ESG Refinitiv
More Ratings

EPS Revisions

Estimates Revisions

Annual profits - Rate of surprise

Company calendar
  1. Stock Market
  2. Equities
  3. 2096 Stock
  4. Consensus Simcere Pharmaceutical Group Limited